CLDN4 and breast cancer: Previous studies have shown that claudin-4 is associated with prognosis in breast or bladder cancer, and plays a role in breast cancer cell invasiveness and metastatic potential in addition to inducing angiogenic factors in ovarian cancer [20, 45-47].